Ticker AVDL – Avadel Pharma – sales, description, marketcap – Tickerday.com

AVDL

Avadel Pharma

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 299.25M; Volume: 161.60K; AvgVol 3m: 870.58K; Beta: 1.32;

Cost estimate:

P/E: 327.60; EPS: -0.11; EPS growth quarter/prev quarter: 291.60%;

EPS growth this year: 65.30%; EPS growth past 5 years: 18.50%;

EPS ttm: -0.11;

P/S: 6.35; P/B: 1.55; P/Cashflow: 1.27; P/FCF: ;

Sales: 47.55M; Sales growth quarter/prev quarter: -42.60%; Sales growth past 5 years: 31.60%;

Profitability:

Gross Margin: 76.90%; Profit Margin: 38.70%; Operating Margin: 47.10%;

ROA – return on assets: 8.60%; ROE – return on equity: 46.60%; LT Debt/Equity: 0.69; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.50%; Insider Transactions:;

Institutional Ownership: 64.20%; Institutional Transactions: 33.14%;

Data update: 07/10/2020.